Ocular manifestations of late-onset behçet disease.
OBJECTIVE
to describe the demographic characteristics and ocular manifestations of patients with late-onset Behçet disease (BD).


METHODS
The patients for this retrospective study were selected using the data obtained from the medical records of 16 patients with late-onset BD between January 2000 and May 2008.


RESULTS
twelve (75%) of the cases were male and 4 (25%) were female. The mean age of patients was 53.8 ± 2.9 years (range, 51-60 years). The mean follow-up period was 4.3 ± 1.1 years (range, 3-8 years). Throughout the follow-up period, panuveitis, posterior uveitis, and anterior uveitis were detected in 11 (68.7%), 4 (25%) and 1 (6.2%) of 16 patients, respectively.


CONCLUSIONS
in our series, the most frequent type of uveitis was panuveitis and male sex seems to be a significant risk factor for developing panuveitis. Late-onset BD showed a marked preponderance of males with a sex ratio of 3:1.
Citirik
Mehmet
M
SB Ankara Ulucanlar Eye Education and Research Hospital, Ankara, Turkey. mcitirik @ hotmail.com
Berker
Nilufer
N
Songur
Murat Serkan
MS
Ozkan
Seyhan Sonar
SS
Zilelioglu
Orhan
O
D001528:Behcet Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D015864:Panuveitis / Q000175:diagnosis* / Q000188:drug therapy; D012189:Retrospective Studies; D012307:Risk Factors; D017678:Sex Distribution; D014606:Uveitis, Anterior / Q000175:diagnosis* / Q000188:drug therapy; D015866:Uveitis, Posterior / Q000175:diagnosis* / Q000188:drug therapy; D014792:Visual Acuity / Q000502:physiology
D005938:Glucocorticoids; D007166:Immunosuppressive Agents